Geijteman and colleagues address the question of whether there is excessive end-of-life care in cases of incurable cancer. This study challenges the use of cytotoxic chemotherapy in these situations, with a focus on reducing unnecessary treatments. The research raises important considerations for cancer care, particularly regarding the balance between aggressive treatments and quality of life for patients with incurable cancer. The study highlights the need for a thoughtful and individualized approach to end-of-life care in cancer patients, aiming to improve overall outcomes and patient experience.
Source link